A Dark Vector Cognition product

Item 4. CONTROLS AND PROCEDURES

3K characters. Original on sec.gov ·

Item 4. CONTROLS AND PROCEDURES

The 1 table in Item 4. CONTROLS AND PROCEDURES as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of the Chief Executive

Officer and Chief Financial Officer (the Certifying Officers),

evaluated the effectiveness of the Company's disclosure controls

and procedures (as defined in Rules 13a-15(e) or 15d-15(e)

promulgated under the Securities Exchange Act of 1934, as

amended) on September 30, 2026. Based on that evaluation, the

Certifying Officers concluded the Company's disclosure controls

and procedures were effective as of September 30, 2026.

Changes in Internal Control Over Financial Reporting

There was no change to our internal control over financial

reporting during the nine months 2026 that materially affected, or

is reasonably likely to materially affect, our internal control over

financial reporting.

PART II – OTHER INFORMATION

Item 1A. RISK FACTORS

We are not aware of any material changes to the risk factors

included in Item 1A. "Risk Factors" in our Annual Report on Form

10-K for 2025 and Part II, Item 1A. "Risk Factors" in our Quarterly

Report on Form 10-Q for the quarter ended March 31, 2026.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

In the three months 2026 we did not issue shares of our common

stock as performance incentive awards to employees. When

issued, these shares are not registered under the Securities Act

of 1933 based on the conclusion that the awards would not be

events of sale within the meaning of Section 2(a)(3) of the Act.

In March 2015 we announced that our Board of Directors had

authorized us to purchase up to $2,000 of our common stock. In

October 2026 our Board of Directors approved an increase of

$3,000 to our existing share repurchase program, bringing the

total share repurchase authorization to $3,033. The manner,

timing and amount of repurchases are determined by

management based on an evaluation of market conditions, stock

price, and other factors and are subject to regulatory

considerations. Purchases may be made from time to time in the

open market, in privately negotiated transactions, accelerated

share repurchase programs or otherwise.

In 2026 we repurchased 3 million shares of our common stock at

a cost of $1,000 under our authorized share repurchase program.

The total dollar value of our shares of common stock that could

be acquired under our authorized repurchase program was $33

as of September 30, 2026.

2026 PeriodTotal Number of Shares Purchased (in millions)Average Price Paid Per SharePurchased as Part of Publicly Announced Plans (in millions)Approximate Dollar Value of Shares that may yet be Purchased Under the Plans
July—$——$1,033
August2.8335.172.883
September0.2321.610.233
Total3$334.463

Previous: Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK · Next: Item 5. OTHER INFORMATION